Advertisement
ABCL vs HUMA
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ABCL is a StrongBuy and HUMA is a Buy.
ABCL in +12.31% Uptrend, growing for three consecutive days on November 09, 2026
Moving higher for three straight days is viewed as a bullish sign. Keep an eye on this stock for future growth. Considering data from situations where ABCL advanced for three days, in 207 of 255 cases, the price rose further within the following month. The odds of a continued upward trend are 81%.
Technical Analysis (Indicators)
Bullish Trend Analysis
The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. 49 of 65 cases where ABCL's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 75%.
Bearish Trend Analysis
The Momentum Indicator moved below the 0 level on November 10, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on ABCL as a result. In 74 of 90 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 82%.
The Moving Average Convergence Divergence Histogram (MACD) for ABCL turned negative on November 02, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 42 similar instances when the indicator turned negative. In 34 of the 42 cases the stock turned lower in the days that followed. This puts the odds of success at 81%.
ABCL moved below its 50-day moving average on November 11, 2026 date and that indicates a change from an upward trend to a downward trend.
The 10-day moving average for ABCL crossed bearishly below the 50-day moving average on November 02, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 10 of 13 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 77%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where ABCL declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 82%.
ABCL broke above its upper Bollinger Band on October 28, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Aroon Indicator for ABCL entered a downward trend on November 10, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
Fundamental Analysis (Ratings)
The Tickeron Valuation Rating of 9 (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (4.296) is normal, around the industry mean (3.498). P/E Ratio (-22.000) is within average values for comparable stocks, (-1.193). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (9.059). Dividend Yield (0.000) settles around the average of (130.981) among similar stocks. P/S Ratio (53.191) is also within normal values, averaging (440.869).
The Tickeron Price Growth Rating for this company is 34 (best 1 - 100 worst), indicating steady price growth. ABCL’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is 94 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron PE Growth Rating for this company is 98 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. ABCL’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.
HUMA's MACD Histogram just turned positive
The Moving Average Convergence Divergence (MACD) for HUMA turned positive on October 21, 2026. Looking at past instances where HUMA's MACD turned positive, the stock continued to rise in 36 of 40 cases over the following month. The odds of a continued upward trend are 90%.
Technical Analysis (Indicators)
Bullish Trend Analysis
The Momentum Indicator moved above the 0 level on November 06, 2026. You may want to consider a long position or call options on HUMA as a result. In 78 of 92 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 85%.
HUMA moved above its 50-day moving average on November 10, 2026 date and that indicates a change from a downward trend to an upward trend.
Following a +0.92% 3-day Advance, the price is estimated to grow further. Considering data from situations where HUMA advanced for three days, in 194 of 239 cases, the price rose further within the following month. The odds of a continued upward trend are 81%.
The Aroon Indicator entered an Uptrend today. In 148 of 170 cases where HUMA Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 87%.
Bearish Trend Analysis
The RSI Indicator has been in the overbought zone for 1 day. Expect a price pull-back in the near future.
The Stochastic Oscillator has been in the overbought zone for 1 day. Expect a price pull-back in the near future.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where HUMA declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 89%.
HUMA broke above its upper Bollinger Band on November 10, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
Fundamental Analysis (Ratings)
The Tickeron PE Growth Rating for this company is 14 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Price Growth Rating for this company is 43 (best 1 - 100 worst), indicating steady price growth. HUMA’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Valuation Rating of 72 (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (3.983) is normal, around the industry mean (3.498). P/E Ratio (-0.862) is within average values for comparable stocks, (-1.193). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (9.059). Dividend Yield (0.000) settles around the average of (130.981) among similar stocks. P/S Ratio (52.083) is also within normal values, averaging (440.869).
The Tickeron SMR rating for this company is 100 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. HUMA’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.
ABCL | HUMA | ||
|---|---|---|---|
OUTLOOK RATING 1..100 | 69 | 42 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 9 Undervalued | 72 Overvalued | |
PROFIT vs RISK RATING 1..100 | 100 | 100 | |
SMR RATING 1..100 | 94 | 100 | |
PRICE GROWTH RATING 1..100 | 34 | 43 | |
P/E GROWTH RATING 1..100 | 98 | 14 | |
SEASONALITY SCORE 1..100 | 50 | 25 |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
ABCL's Valuation (9) in the null industry is somewhat better than the same rating for HUMA (72). This means that ABCL’s stock grew somewhat faster than HUMA’s over the last 12 months.
ABCL's Profit vs Risk Rating (100) in the null industry is in the same range as HUMA (100). This means that ABCL’s stock grew similarly to HUMA’s over the last 12 months.
ABCL's SMR Rating (94) in the null industry is in the same range as HUMA (100). This means that ABCL’s stock grew similarly to HUMA’s over the last 12 months.
ABCL's Price Growth Rating (34) in the null industry is in the same range as HUMA (43). This means that ABCL’s stock grew similarly to HUMA’s over the last 12 months.
HUMA's P/E Growth Rating (14) in the null industry is significantly better than the same rating for ABCL (98). This means that HUMA’s stock grew significantly faster than ABCL’s over the last 12 months.
| ABCL | HUMA | |
|---|---|---|
| RSI ODDS (%) | N/A | 1 day ago 83% |
| Stochastic ODDS (%) | 1 day ago 75% | 1 day ago 87% |
| Momentum ODDS (%) | 1 day ago 82% | 1 day ago 85% |
| MACD ODDS (%) | 1 day ago 81% | 1 day ago 90% |
| TrendWeek ODDS (%) | 1 day ago 81% | 1 day ago 86% |
| TrendMonth ODDS (%) | 1 day ago 83% | 1 day ago 87% |
| Advances ODDS (%) | 5 days ago 81% | 1 day ago 81% |
| Declines ODDS (%) | 1 day ago 82% | 12 days ago 89% |
| BollingerBands ODDS (%) | 1 day ago 90% | 1 day ago 88% |
| Aroon ODDS (%) | 1 day ago 82% | 1 day ago 87% |
Long-Term Analysis
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
ABCL’s FA Score shows that 1 FA rating(s) are green while HUMA’s FA Score has 1 green FA rating(s).
- ABCL’s FA Score: 1 green, 4 red.
- HUMA’s FA Score: 1 green, 4 red.
Short-Term Analysis
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
ABCL’s TA Score shows that 2 TA indicator(s) are bullish while HUMA’s TA Score has 5 bullish TA indicator(s).
- ABCL’s TA Score: 2 bullish, 7 bearish.
- HUMA’s TA Score: 5 bullish, 4 bearish.
Price Growth
ABCL (@Biotechnology) experienced а +4.40% price change this week, while HUMA (@Biotechnology) price change was +50.54% for the same time period.
The average weekly price growth across all stocks in the @Biotechnology industry was +2.04%. For the same industry, the average monthly price growth was -6.16%, and the average quarterly price growth was -16.99%.
Reported Earning Dates
ABCL is expected to report earnings on Feb 23, 2027.
HUMA is expected to report earnings on Mar 26, 2027.
Industries' Descriptions
@Biotechnology (+2.04% weekly)Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.
Advertisement
ABCL and
Correlation & Price change
A.I.dvisor indicates that over the last year, ABCL has been loosely correlated with RXRX. These tickers have moved in lockstep 57% of the time. This A.I.-generated data suggests there is some statistical probability that if ABCL jumps, then RXRX could also see price increases.
| Ticker / NAME | Correlation To ABCL | 1D Price Change % | ||
|---|---|---|---|---|
| ABCL | 100% | -2.76% | ||
| RXRX - ABCL | 57% Loosely correlated | -7.24% | ||
| ABSI - ABCL | 57% Loosely correlated | -9.73% | ||
| CRSP - ABCL | 56% Loosely correlated | -6.84% | ||
| VCYT - ABCL | 56% Loosely correlated | -1.91% | ||
| NTLA - ABCL | 55% Loosely correlated | -7.54% | ||
More | ||||
HUMA and
Correlation & Price change
A.I.dvisor indicates that over the last year, HUMA has been loosely correlated with PROK. These tickers have moved in lockstep 36% of the time. This A.I.-generated data suggests there is some statistical probability that if HUMA jumps, then PROK could also see price increases.
| Ticker / NAME | Correlation To HUMA | 1D Price Change % | ||
|---|---|---|---|---|
| HUMA | 100% | +0.63% | ||
| PROK - HUMA | 36% Loosely correlated | +1.77% | ||
| ABCL - HUMA | 35% Loosely correlated | -2.76% | ||
| CRSP - HUMA | 35% Loosely correlated | -6.84% | ||
| EDIT - HUMA | 34% Loosely correlated | -10.08% | ||
| SANA - HUMA | 34% Loosely correlated | -12.23% | ||
More | ||||
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| FMCX | 36.83 | N/A | N/A |
| FM Focus Equity ETF (FMCX) | |||
| FMTL | 31.72 | -0.63 | -1.95% |
| First Trust Indxx Critical Metals ETF (FMTL) | |||
| DEHP | 36.13 | -0.77 | -2.08% |
| Dimensional Emerging Markets High Profitability ETF (DEHP) | |||
| XOVL | 17.55 | -0.40 | -2.22% |
| Defiance Daily Target 2X Long XOVR ETF (XOVL) | |||
| ICLN | 15.90 | -0.38 | -2.33% |
| iShares Global Clean Energy ETF (ICLN) | |||